improves Metabolic & barrier health
Pasteurized Akkermansia muciniphila was safe and improved insulin sensitivity and metabolic markers in overweight, insulin-resistant adults.
Nature Medicine, 2019 · PubMed 31263284 DOI
Akkermansia
In one paragraph
Akkermansia muciniphila is a mucin-degrading, Gram-negative anaerobic bacterium that resides in the intestinal mucus layer and typically represents roughly 1-5% of the human gut microbiota. A flagship pilot RCT and 2025-2026 follow-up trials show real but modest benefits on insulin sensitivity, weight and HbA1c, but the trial base is small, a 2026 multicenter trial missed its primary endpoint, and benefits may appear mainly in people with low baseline Akkermansia.
Source: Nature Medicine 2019, PMID 31263284 ↗ · Evidence-graded supplements · Research map · Study write-up · evidence confidence: medium
Akkermansia muciniphila is a keystone gut microbe that protects the intestinal barrier and declines with age and metabolic disease; a human pilot improved metabolic markers and it extended lifespan in progeroid mice.
Keystone mucin-degrading microbe; protects the gut barrier, declines with age.
Research-backed interactions
Products
Gut–Immune AxisCurated supplements. Links are affiliate (Amazon Associates, tag magellanlong-20) — we may earn a commission at no cost to you.
Frequently asked
How does Akkermansia relate to longevity?
Akkermansia muciniphila is a keystone gut microbe that protects the intestinal barrier and declines with age and metabolic disease; a human pilot improved metabolic markers and it extended lifespan in progeroid mice.
How is Akkermansia related to Metabolic & barrier health?
Pasteurized Akkermansia muciniphila was safe and improved insulin sensitivity and metabolic markers in overweight, insulin-resistant adults.